Franklin Resources
GMAB icon

Franklin Resources’s Genmab GMAB Stock Holding History

Franklin Resources’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32M Buy
1,193,145
+1,162,495
+3,793% +$34.8M 0.01% 794
2025
Q4 		$944K Sell
30,650
-690
-2% -$21.5K ﹤0.01% 2117
2025
Q3 		$961K Buy
31,340
+1,186
+4% +$28.9K ﹤0.01% 2119
2025
Q2 		$623K Sell
30,154
-1,055
-3% -$21.7K ﹤0.01% 2221
2025
Q1 		$611K Buy
31,209
+313
+1% +$6.57K ﹤0.01% 2179
2024
Q4 		$645K Buy
30,896
+5,233
+20% +$115K ﹤0.01% 2178
2024
Q3 		$607K Sell
25,663
-1,404
-5% -$37.5K ﹤0.01% 2193
2024
Q2 		$680K Sell
27,067
-3,583
-12% -$102K ﹤0.01% 2102
2024
Q1 		$917K Buy
30,650
+299
+1% +$8.78K ﹤0.01% 1992
2023
Q4 		$966K Sell
30,351
-527,256
-95% -$16.6M ﹤0.01% 1660
2023
Q3 		$19.7M Sell
557,607
-88,030
-14% -$3.35M 0.01% 747
2023
Q2 		$24.5M Buy
645,637
+111,451
+21% +$4.44M 0.01% 718
2023
Q1 		$20.2M Buy
534,186
+92,824
+21% +$3.57M 0.01% 764
2022
Q4 		$18.7M Buy
441,362
+431,763
+4,498% +$17.8M 0.01% 791
2022
Q3 		$309K Sell
9,599
-174
-2% -$6.11K ﹤0.01% 1841
2022
Q2 		$318K Buy
9,773
+3,342
+52% +$108K ﹤0.01% 1850
2022
Q1 		$233K Sell
6,431
-420
-6% -$14.4K ﹤0.01% 2103
2021
Q4 		$271K Buy
6,851
+915
+15% +$38.2K ﹤0.01% 2128
2021
Q3 		$259K Buy
5,936
+391
+7% +$17.6K ﹤0.01% 2136
2021
Q2 		$226K Buy
+5,545
New +$214K ﹤0.01% 1814
2021
Q1 		– Sell
-5,111
Closed -$208K – 1998
2020
Q4 		$208K Buy
+5,111
New +$191K ﹤0.01% 1719

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Franklin Resources's GMAB Position: Q1 2026 in Review

Franklin Resources increased its Genmab (GMAB) stake by 3,793% in Q1 2026, buying an estimated $34.8M and bringing the position to 1,193,145 shares worth $32M. The position accounts for 0.01% of the portfolio, ranked #794.

Franklin Resources first reported a position in GMAB in Q4 2020 and has held it in 21 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Franklin Resources held 1,193,145 shares of Genmab worth $32M as of Q1 2026.
  • Franklin Resources bought 1,162,495 Genmab shares in Q1 2026, an estimated $34.8M.
  • Genmab made up 0.01% of Franklin Resources's portfolio in Q1 2026, its #794 holding.
  • Franklin Resources first reported a position in Genmab in Q4 2020 and has held it in 21 quarters since.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.